title: [Our treatment approach for preterm birth].
authors.forename: A
authors.initials: A
authors.lastname: Museva
authors.forename: A
authors.initials: A
authors.lastname: Dimitrov
authors.forename: B
authors.initials: B
authors.lastname: Marinov
authors.forename: E
authors.initials: E
authors.lastname: Shopova
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D058666:Adrenergic beta-2 Receptor Agonists / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002031:Bulgaria / Q000453:epidemiology; D005260:Female; D005280:Fenoterol / Q000627:therapeutic use; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007231:Infant, Newborn; D008274:Magnesium / Q000627:therapeutic use; D047928:Premature Birth / Q000188:drug therapy* / Q000453:epidemiology*; D015149:Tocolytic Agents / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D058666:Adrenergic beta-2 Receptor Agonists; D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D015149:Tocolytic Agents; D005280:Fenoterol; D008274:Magnesium; D007213:Indomethacin